Literature DB >> 3730180

Antibody dependent cellular cytotoxicity (ADCC)-reaction and an in vitro steroid sensitivity test of peripheral lymphocytes in children with malignant haematological and autoimmune diseases.

A László, I Petri, M Ilyés.   

Abstract

ADCC reaction (antibody dependent cellular cytotoxicity), ADCC capacity and ADCC steroid sensitivity examinations were performed in 20 children with tumorous or haematological diseases, 10 children with autoimmune diseases, and appropriate controls, in order to establish the killer function and steroid sensitivity. In the above diseases a study was also made of the correlation of the individual reactions with the duration of steroid therapy. The two patient groups did not exhibit a significant difference from the controls as concerns the ADCC reaction and ADCC capacity. In the group of tumorous or malignant haematological diseases the steroid sensitivity behaved in a different way, with sensitivity in 45%, moderate sensitivity in 20%, and steroid resistance in 35% of the patients. Steroid inhibition of the ADCC reaction was significantly decreased in the group of autoimmune patients. There was no correlation between ADCC reaction and ADCC steroid sensitivity or resistance in either group, and thus the ADCC steroid resistance or sensitivity and lymphocyte killer function proved to be independent. No correlation was found between the steroid sensitivity or resistance and the duration of steroid treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730180

Source DB:  PubMed          Journal:  Acta Paediatr Hung        ISSN: 0231-441X


  6 in total

1.  Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Authors:  Anne-Sophie Dugast; Andrew Tonelli; Christoph T Berger; Margaret E Ackerman; Gaia Sciaranghella; Qingquan Liu; Magdalena Sips; Ildiko Toth; Alicja Piechocka-Trocha; Musie Ghebremichael; Galit Alter
Journal:  Virology       Date:  2011-05-12       Impact factor: 3.616

2.  A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.

Authors:  Margaret E Ackerman; Brian Moldt; Richard T Wyatt; Anne-Sophie Dugast; Elizabeth McAndrew; Stephen Tsoukas; Stephanie Jost; Christoph T Berger; Gaia Sciaranghella; Qingquan Liu; Darrell J Irvine; Dennis R Burton; Galit Alter
Journal:  J Immunol Methods       Date:  2010-12-27       Impact factor: 2.303

3.  Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.

Authors:  Martin Felices; Todd R Lenvik; Zachary B Davis; Jeffrey S Miller; Daniel A Vallera
Journal:  Methods Mol Biol       Date:  2016

4.  Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.

Authors:  Giovanna Peruzzi; Laurette Femnou; Aleksandra Gil-Krzewska; Francisco Borrego; Jennifer Weck; Konrad Krzewski; John E Coligan
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

Review 5.  The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Authors:  Bree Foley; Martin Felices; Frank Cichocki; Sarah Cooley; Michael R Verneris; Jeffrey S Miller
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 6.  Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.

Authors:  Zachary B Davis; Daniel A Vallera; Jeffrey S Miller; Martin Felices
Journal:  Semin Immunol       Date:  2017-09-05       Impact factor: 11.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.